Antimikrobielle Therapie bei intensivpflichtigen Patienten mit akuter Exazerbation einer COPD

Aburto M, Esteban C, Moraza FJ et al (2011) COPD exacerbation: mortality prognosis factors in a respiratory care unit. Arch Bronconeumol 47:79–84 Añón JM, García de Lorenzo A, Zarazaga A et al (1999) Mechanical ventilation of patients on long-term oxygen therapy with acute exacerbations of chronic obstructive pulmonary disease: prognosis and cost-utility analysis. Intensive Care Med 25:452–457 Anthonisen NR, Manfreda J, Warren CP et al (1987) Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106:196–204 Cameron RJ, Wit D de, Welsh TN et al (2006) Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation. Intensive Care Med 32:1022–1029 Chu CM, Chan VL, Lin AWN et al (2004) Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 59:1020–1025 Daniels JMA, Schoorl M, Snijders D et al (2010) Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD. Chest 138:1108–1115 Daniels JMA, Snijders D, Graaff CS de et al (2010) Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 181:150–157 Daubin C, Parienti JJ, Vabret A et al (2008) Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study. BMC Infect Dis 8:145 Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA (2002) Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57:847–852 Ewig S, Schaberg T (2006) Ein neues Konzept der antimikrobiellen Therapie von Patienten mit akuter Exazerbation der chronisch-obstruktiven Lungenerkrankung (COPD). Pneumologie 60:295–304 Ewig S, Soler N, Gonzalez J et al (2000) Evaluation of antimicrobial treatment in mechanically ventilated patients with severe chronic obstructive pulmonary disease exacerbations. Crit Care Med 28:692–697 Fagon JY, Chastre J, Trouillet JL et al (1990) Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. Am Rev Respir Dis 142:1004–1008 Garcia-Vidal C, Almagro P, Romaní V et al (2009) Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study. Eur Respir J 34:1072–1078 Groenewegen KH, Schols AMWJ, Wouters EFM (2003) Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 124:459–467 Halbert RJ, Natoli JL, Gano A et al (2006) Global burden of COPD: systematic review and meta-analysis. Eur Respir J 28:523–532 Höffken G, Lorenz J, Kern W et al (2009) Epidemiologie, Diagnostik, antimikrobielle Therapie und Management von erwachsenen Patienten mit ambulant erworbenen unteren Atemwegsinfektionen sowie ambulant erworbener Pneumonie – Update 2009. S3-Leitlinie der Paul-Ehrlich-Gesellschaft für Chemotherapie, der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin, der Deutschen Gesellschaft für Infektiologie und vom Kompetenznetzwerk CAPNETZ. Pneumologie 63:e1–68 Miravitlles M, Torres A (2004) No more equivalence trials for antibiotics in exacerbations of COPD, please. Chest 125:811–813 Monsó E, Garcia-Aymerich J, Soler N et al (2003) Bacterial infection in exacerbated COPD with changes in sputum characteristics. Epidemiol Infect 131:799–804 Nicotra MB, Rivera M, Awe RJ (1982) Antibiotic therapy of acute exacerbations of chronic bronchitis. A controlled study using tetracycline. Ann Intern Med 97:18–21 Nouira S, Marghli S, Belghith M et al (2001) Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial. Lancet 358:2020–2025 Nouira S, Marghli S, Besbes L et al (2010) Standard versus newer antibacterial agents in the treatment of severe acute exacerbation of chronic obstructive pulmonary disease: a randomized trial of trimethoprim-sulfamethoxazole versus ciprofloxacin. Clin Infect Dis 51:143–149 Nseir S, Di Pompeo C, Cavestri B et al (2006) Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: prevalence, risk factors, and outcome. Crit Care Med 34:2959–2966 Rammaert B, Verdier N, Cavestri B, Nseir S (2009) Procalcitonin as a prognostic factor in severe acute exacerbation of chronic obstructive pulmonary disease. Respirology 14:969–974 Rodriguez-Roisin R, Anzueto A, Bourbeau J et al (2011) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (revised 2011). From the global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). http://www.goldcopd.org/. Zugegriffen: 01. März 2012 Sethi S, Maloney J, Grove L et al (2006) Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173:991–998 Sethi S, Sethi R, Eschberger K et al (2007) Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176:356–361 Soler N, Agustí C, Angrill J et al (2007) Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease. Thorax 62:29–35 Soler N, Torres A, Ewig S et al (1998) Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 157:1498–1505 Stockley RA, O’Brien C, Pye A, Hill SL (2000) Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 117:1638–1645 Stolz D, Christ-Crain M, Bingisser R et al (2007) Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 131:9–19 Woodhead M, Blasi F, Ewig S et al (2011) Guidelines for the management of adult lower respiratory tract infections – full version. Clin Microbiol Infect 17(Suppl 6):E1–59